Ciprofibrate is a fibrate that was developed as a lipid-lowering agent. It was patented in 1972 and approved for medical use in 1985. Ciprofibrate primarily manages hyperlipidemia, reducing elevated levels of triglycerides and low-density lipoprotein (LDL) cholesterol in the blood. It works by activating peroxisome proliferator-activated receptors (PPARs) in the liver, which helps decrease triglyceride production and increase high-density lipoprotein (HDL) cholesterol levels. Ciprofibrate is often prescribed to reduce the risk of cardiovascular events in patients with high cholesterol who have not responded adequately to lifestyle changes or other medications.
Parent: Ciprofibrate
Parent: Ciprofibrate
Parent: Ciprofibrate
Parent: Ciprofibrate
Parent: Ciprofibrate
During the production and storage of Ciprofibrate, impurities may form, and these must be controlled to ensure the medication’s safety and efficacy. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) provide guidelines for acceptable impurity levels.
Ciprofibrate is used to manage hyperlipidemia, specifically to lower elevated levels of triglycerides and LDL cholesterol and to increase HDL cholesterol in patients with dyslipidemia. It is often prescribed when lifestyle changes and other medications have not effectively managed cholesterol levels.
Ciprofibrate is not approved by the FDA for use in the United States, though it is available in several other countries. Healthcare providers in the U.S. may recommend alternative lipid-lowering fibrates like fenofibrate, which are FDA-approved.
Ciprofibrate and Fenofibrate are both fibrates, but Ciprofibrate has a longer duration of action, often requiring a lower daily dose. However, the choice between the two depends on the patient’s specific health needs, potential side effects, and the availability of the medications in their country.
Ciprofibrate is typically taken once daily, with or without food, as advised by a healthcare provider. Consistency in taking the medication at the same time each day is recommended to maintain stable levels in the bloodstream. Patients should follow their doctor’s instructions regarding the timing of the dose.
